{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Gastrointestinal epithelial barrier disorders",
      "relation": "indication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_mesalamine",
          "type": "Drug",
          "label": "Mesalamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_budesonide",
          "type": "Drug",
          "label": "Budesonide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_vancomycin",
          "type": "Drug",
          "label": "Vancomycin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_loperamide",
          "type": "Drug",
          "label": "Loperamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_probiotics",
          "type": "Drug",
          "label": "Probiotics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_octreotide",
          "type": "Drug",
          "label": "Octreotide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_epithelial_barrier",
          "type": "Target",
          "label": "Epithelial Barrier",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_inflammatory_response",
          "type": "Pathway",
          "label": "Inflammatory Response Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_microbiota_interaction",
          "type": "Pathway",
          "label": "Microbiota Interaction Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_gastrointestinal_disorder",
          "type": "Disease",
          "label": "Gastrointestinal Disorder",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Mesalamine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Budesonide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Azathioprine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Vancomycin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Loperamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Probiotics",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Octreotide",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_mesalamine",
          "target": "target_epithelial_barrier",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知对肠道上皮屏障有改善作用"
        },
        {
          "source": "drug_budesonide",
          "target": "target_epithelial_barrier",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "对肠上皮的抗炎作用"
        },
        {
          "source": "drug_infliximab",
          "target": "target_epithelial_barrier",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "用于治疗炎症群体的有效性"
        },
        {
          "source": "drug_adalimumab",
          "target": "target_epithelial_barrier",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "相似机制用于肠道炎症疾病"
        },
        {
          "source": "drug_ustekinumab",
          "target": "target_epithelial_barrier",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "对小肠和大肠炎症均有影响"
        },
        {
          "source": "drug_azathioprine",
          "target": "target_epithelial_barrier",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "用于免疫抑制，改善肠道健康"
        },
        {
          "source": "drug_methotrexate",
          "target": "target_epithelial_barrier",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "抑制免疫反应以影响肠道"
        },
        {
          "source": "drug_vancomycin",
          "target": "pathway_microbiota_interaction",
          "relation": "involved_in",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "结合微生物群体的作用"
        },
        {
          "source": "drug_loperamide",
          "target": "disease_gastrointestinal_disorder",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于治疗腹泻和肠道相关症状"
        },
        {
          "source": "drug_tacrolimus",
          "target": "target_epithelial_barrier",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "免疫调节机制影响上皮屏障"
        },
        {
          "source": "drug_probiotics",
          "target": "pathway_microbiota_interaction",
          "relation": "involved_in",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "促进肠道微生物均衡"
        },
        {
          "source": "drug_octreotide",
          "target": "target_epithelial_barrier",
          "relation": "acts_on",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "影响肠道激素水平，促进上皮修复"
        },
        {
          "source": "target_epithelial_barrier",
          "target": "pathway_inflammatory_response",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "刺激炎症通路以修复损伤"
        },
        {
          "source": "pathway_inflammatory_response",
          "target": "disease_gastrointestinal_disorder",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "炎症机制驱动疾病演化"
        },
        {
          "source": "pathway_microbiota_interaction",
          "target": "disease_gastrointestinal_disorder",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "微生物干预可影响肠道状态"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.76,
          "components": {
            "mechanism_fit": 0.9,
            "class_prior": 0.7,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.75,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 1.7,
            "contradiction_weight": 0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Mesalamine直接作用于肠道上皮屏障，改善肠道功能"
            ],
            "safety_risk": [
              "未识别显著的安全风险"
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H2",
          "score": 0.73,
          "components": {
            "mechanism_fit": 0.85,
            "class_prior": 0.7,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.75,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 1.7,
            "contradiction_weight": 0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Budesonide通过抗炎作用改善肠上皮的状况"
            ],
            "safety_risk": [
              "未识别显著的安全风险"
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H3",
          "score": 0.8,
          "components": {
            "mechanism_fit": 0.9,
            "class_prior": 0.8,
            "pk_pd_feasibility": 0.75,
            "indication_plausibility": 0.8,
            "safety_risk": 0.15,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 1.7,
            "contradiction_weight": 0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Infliximab通过抑制炎症反应帮助修复肠道上皮"
            ],
            "safety_risk": [
              "未识别显著的安全风险"
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H4",
          "score": 0.78,
          "components": {
            "mechanism_fit": 0.9,
            "class_prior": 0.75,
            "pk_pd_feasibility": 0.75,
            "indication_plausibility": 0.8,
            "safety_risk": 0.15,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 1.7,
            "contradiction_weight": 0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Adalimumab通过类似机制作用于肠道炎症改善"
            ],
            "safety_risk": [
              "未识别显著的安全风险"
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H5",
          "score": 0.76,
          "components": {
            "mechanism_fit": 0.85,
            "class_prior": 0.7,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.75,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 1.5,
            "contradiction_weight": 0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Ustekinumab针对于小肠与大肠的炎症均有作用"
            ],
            "safety_risk": [
              "未识别显著的安全风险"
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H6",
          "score": 0.7,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.65,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.7,
            "safety_risk": 0.25,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 1.3,
            "contradiction_weight": 0.1,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Azathioprine能够通过免疫抑制效果改善肠道健康"
            ],
            "safety_risk": [
              "存在较高的潜在安全风险"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H7",
          "score": 0.68,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.65,
            "safety_risk": 0.3,
            "graph_bonus": 0.05,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 1.2,
            "contradiction_weight": 0.2,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Methotrexate能够通过抑制免疫反应影响肠道"
            ],
            "safety_risk": [
              "存在较高的潜在安全风险"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H8",
          "score": 0.64,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.65,
            "safety_risk": 0.25,
            "graph_bonus": 0.05,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.65,
            "contradiction_weight": 0.1,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Vancomycin通过影响微生物群体间接影响肠道状态"
            ],
            "safety_risk": [
              "可能的安全性问题需测试"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "缺乏直接作用于上皮的证据"
          ]
        },
        {
          "hypothesis_id": "H9",
          "score": 0.55,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.55,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.2,
            "graph_bonus": 0.05,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.1,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Loperamide用于缓解腹泻和肠道症状，间接改善肠道功能"
            ],
            "safety_risk": [
              "潜在的安全风险需要评估"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H10",
          "score": 0.53,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.55,
            "safety_risk": 0.3,
            "graph_bonus": 0.05,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.55,
            "contradiction_weight": 0.1,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Tacrolimus有免疫调节作用，但影响肠道防御的机制不够明确"
            ],
            "safety_risk": [
              "潜在的安全风险需要进一步评估"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H11",
          "score": 0.6,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.2,
            "graph_bonus": 0.05,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.5,
            "contradiction_weight": 0.1,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Probiotics通过促进微生物均衡直接影响肠道健康，但机制不够明确"
            ],
            "safety_risk": [
              "缺乏安全性数据"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H12",
          "score": 0.58,
          "components": {
            "mechanism_fit": 0.55,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.05,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.5,
            "contradiction_weight": 0.1,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Octreotide通过影响激素水平影响肠道，但直接效果尚存疑问"
            ],
            "safety_risk": [
              "潜在的安全性问题需测试"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_mesalamine",
            "via": [
              "target_epithelial_barrier"
            ],
            "to": "disease_gastrointestinal_disorder",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          },
          {
            "type": "stress_test_safety",
            "topic": "肠道上皮屏障改善的长期安全性",
            "expectation": "如存在明显安全风险，需标注高权重的 refutes 边",
            "assignee": "Skeptic"
          },
          {
            "type": "merge_claims",
            "nodes": [
              "H1",
              "H2",
              "H3",
              "H4",
              "H5"
            ],
            "rationale": "候选之间机制相似，降低冗余信息",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "不同药剂对肠道上皮屏障的具体影响",
          "长期使用的安全性与效果的权衡"
        ]
      }
    ],
    "seed_request": {
      "should_regenerate": false,
      "reason": "现有候选机制具有较高的重叠程度，且在临床上均已被使用，重点需通过更深入的安全性评估而非引入新种子。",
      "n": 4
    }
  }
}